
Because they’re often given drugs that suppress their immune systems, people battling a blood cancer known as multiple myeloma have varying responses to the COVID-19 vaccine, new research shows. Some patients had no evidence at all of COVID-fighting antibody production after getting two doses of vaccine, the new study found. In a minority of cases,… read on > read on >